7c: Geriatric Depression

Geriatric Depression: Prevalence and Clinical Features

  • Classifications and Prevalence

    • Geriatric depression primarily encompasses Major Depression and Dysthymia, the latter of which is now referred to as Persistent Depressive Disorder.

    • In individuals over the age of 6565, the prevalence of depression is approximately 1%1\%.

    • There is a significant disparity in prevalence rates based on the living environment:

      • Residential Care: Approximately 32%32\% an prevalence rate.

      • Community Settings: Approximately 14.4%14.4\% an prevalence rate.

    • High rates of suicide are a critical concern within this demographic.

  • Symptomatology and Presentation

    • Memory issues are the most frequently reported symptom by the patients themselves.

    • Clinical presentation is often complicated by difficulties in distinguishing depressive symptoms from those arising from other comorbid medical conditions or side effects of medications.

  • Late-Onset Depression (After Age 6060)

    • Depression occurring for the first time after age 6060 typically exhibits specific characteristics:

      • Greater levels of cognitive dysfunction.

      • Higher rates of physical fatigue.

      • Significant comorbidity with other medical illnesses.

      • A less pronounced biological link compared to early-onset depression.

      • Generally follows a chronic course with a poor prognosis.

  • Treatment Modalities

    • Cognitive-Behavioural Therapy (CBT): Utilized for restructuring negative thought patterns.

    • Interpersonal Therapy (IPT): Focused on improving the quality of social interactions and relationships.

    • Antidepressant Medications: Pharmacological intervention.

    • Combinations: Integrating psychological therapies with medication for optimal outcomes.


Differential Diagnosis: Depression vs. Dementia

Distinguishing between depression and dementia is essential due to overlapping symptoms. The following distinctions are noted:

  • Depression Profile

    • Reporting: Patients tend to overreport their cognitive symptoms.

    • Cognitive Deficits: Primarily manifest as attention and executive dysfunction problems.

    • Vegetative Symptoms: Present throughout the duration of the illness.

    • Awareness: The patient is often the one to identify and voice the problem.

    • Test Performance: Performance on cognitive tests improves with effort, particularly if the clinical affect of the patient is increased during the session.

  • Dementia Profile

    • Reporting: Patients tend to underreport their cognitive symptoms.

    • Cognitive Deficits: Includes a range of cognitive problems, with memory loss being prominent.

    • Vegetative Symptoms: Typically only emerge in the later stages of the disorder.

    • Awareness: Family members, caregivers, or others notice the symptoms more than the patient does.

    • Test Performance: The patient will not show improvement on test results, regardless of their affect or the effort they apply.


Delirium: Characteristics and Differential Diagnosis

  • Clinical Definition of Delirium

    • An altered state of consciousness characterized by an acute onset and reversible disturbance.

    • Core symptoms include:

      • Difficulty concentrating.

      • Disruption of the sleep-wake cycle.

      • Incoherent or rambling speech.

      • Memory impairment.

      • Perceptual disturbances.

      • Fluctuating mood and activity swings.

  • Differential Diagnosis: Delirium vs. Dementia

    • Delirium Characteristics:

      • Reversible with appropriate medical treatment.

      • Affects individuals of all ages (both young and old).

      • Acute condition with sudden onset.

      • Notable fluctuations in alertness, attention, and global cognition.

      • Speech may appear incoherent, similar to the appearance of intoxication or psychosis.

      • Important note: Delirium can occur as a superimposed condition in those who already have dementia.

    • Dementia Characteristics:

      • While sometimes reversible, it is more often deteriorative/degenerative.

      • Prevalence increases significantly with age.

      • Characterized by a progressive decline of cognitive abilities over time.

      • Leads to functional impairment in daily living.

      • May be associated with permanent personality changes and psychotic symptoms.


Assessment and Treatment for Neurocognitive Disorders

  • Assessment Procedures

    • Accurate diagnosis is paramount and is achieved through:

      • Clinical History: Detailed background of the patient's symptoms and health.

      • Neuropsychological Assessments: Testing cognitive functions.

      • Neuroimaging: Visualizing brain structures and activity.

    • Early diagnosis is critical as it improves clinical outcomes and facilitates long-term planning for the patient.

  • Treatment and Management Levels (Stepped Supervision)

    • Management often follows a progression of care intensity:

      • Monitoring

      • Supervision

      • Assisted living

      • Nursing care

  • Therapeutic Interventions

    • Supportive Care: Includes psychoeducation, psychotherapy, and specialized nursing care.

    • Medications: These treat secondary symptoms rather than providing a cure. Common drugs include:

      • Cholinesterase inhibitors.

      • Antidepressants and antipsychotics.

    • Psychological Treatment: Targeted toward managing behavioral symptoms such as wandering or aggression.

  • Lifestyle Factors and Management Strategies

    • Evidence suggests the protective influence of lifestyle factors against cognitive decline: diet, physical exercise, and cognitive stimulation.

    • Effective management strategies include:

      • Implementing specific communication strategies.

      • Modifying the physical environment for safety and clarity.

      • Providing pleasant and engaging activities for the patient.


Body, Brain, Life (BBL) Project

  • Overview

    • The Body, Brain, Life (BBL) project is a research initiative by the National Centre for Epidemiology and Population Health at the Australian National University (ANU) College of Health & Medicine.

    • Funded by the Dementia Collaborative Research Centres.

    • Researcher: Professor Nicolas Cherbuin.

  • The Intervention

    • A novel online intervention designed for middle-aged individuals at risk of dementia.

    • Focuses on sustaining lifestyle changes to reduce the risk profile for dementia.

    • Based on behavior change principles and modifiable risk factors identified through research.

  • Randomised Controlled Trial (RCT) Results

    • The trial involved 176176 middle-aged adults.

    • Three groups were compared:

      1. Standard online intervention.

      2. Online intervention augmented with face-to-face group sessions.

      3. Control group receiving weekly emails with links to health websites.

    • Outcome: Participation in the BBL intervention led to a significantly reduced score on the ANU-Alzheimer's Disease Risk Index.

    • The project is currently listed as completed.


Community and Societal Implications

  • Dementia-Friendly Communities

    • The goal is to reduce stigma and promote awareness to create safer environments for those with neurocognitive disorders.

    • The initiative seeks to empower people living with dementia to make their own life decisions.

    • Kate Swaffer of Dementia Alliance International emphasizes that dementia-friendly communities are a matter of human rights and disability rights, allowing individuals to remain independent as long as possible.

  • Hogeweyk Dementia Village

    • A specific real-world example of an innovative care model where residents live in a designed village setting that mimics normal life while providing high-level care.


Summary Statistics and Future Projections

  • Population Trends

    • The aging population has led to an increased emphasis on geriatric conditions within the healthcare system.

    • By the year 20502050, it is projected that 3,000,0003,000,000 Australians will be living with dementia.

  • Prevalent Neurocognitive Disorders

    • Alzheimer's Disease is categorized as the most prevalent form of dementia.

    • Other significant forms mentioned include Frontotemporal dementia, Lewy body dementia, and Parkinson’s-related cognitive decline.

    • Geriatric depression remains a major comorbid and independent concern for this population.